- Home
- CCI vs RGC Comparison
CCI vs RGC Comparison
Compare CCI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCI
- RGC
- Stock Information
- Founded
- CCI 1994
- RGC 2014
- Country
- CCI United States
- RGC Hong Kong
- Employees
- CCI N/A
- RGC N/A
- Industry
- CCI Real Estate Investment Trusts
- RGC Medicinal Chemicals and Botanical Products
- Sector
- CCI Real Estate
- RGC Health Care
- Exchange
- CCI Nasdaq
- RGC Nasdaq
- Market Cap
- CCI 43.5B
- RGC 38.6B
- IPO Year
- CCI 1998
- RGC 2021
- Fundamental
- Price
- CCI $104.53
- RGC $13.97
- Analyst Decision
- CCI Buy
- RGC
- Analyst Count
- CCI 18
- RGC 0
- Target Price
- CCI $121.17
- RGC N/A
- AVG Volume (30 Days)
- CCI 3.3M
- RGC 644.3K
- Earning Date
- CCI 07-23-2025
- RGC 06-30-2025
- Dividend Yield
- CCI 4.07%
- RGC N/A
- EPS Growth
- CCI N/A
- RGC N/A
- EPS
- CCI N/A
- RGC N/A
- Revenue
- CCI $6,468,000,000.00
- RGC N/A
- Revenue This Year
- CCI N/A
- RGC N/A
- Revenue Next Year
- CCI $3.02
- RGC N/A
- P/E Ratio
- CCI N/A
- RGC N/A
- Revenue Growth
- CCI 6.36
- RGC N/A
- 52 Week Low
- CCI $84.20
- RGC $0.09
- 52 Week High
- CCI $120.92
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- CCI 47.01
- RGC 46.62
- Support Level
- CCI $104.69
- RGC $12.60
- Resistance Level
- CCI $112.75
- RGC $14.26
- Average True Range (ATR)
- CCI 2.91
- RGC 1.25
- MACD
- CCI -0.60
- RGC 0.18
- Stochastic Oscillator
- CCI 2.52
- RGC 23.60
About CCI Crown Castle Inc.
Crown Castle owns and leases roughly 40,000 cell towers in the United States. It also owns more than 90,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. Crown Castle's towers and fiber are predominantly in the largest US cities. The company has a very concentrated customer base, with about 75% of its revenue from the Big Three US mobile carriers. Crown Castle operates as a real estate investment trust. It has announced plans to divest its fiber business, which should be finalized in 2026. After that, Crown will be a stand-alone tower operator.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.